Johnson & Johnson (JNJ): FY25 Q3 earnings call, Oct 14, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Oct 14, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “Europe”; 2 quoted, at least 25 words apart.
…and its potential continues to build with the approval this quarter in Europe as a treatment for high-risk smoldering multiple myeloma, as well as promising…
…brought this latest member of the AccuView Oasis MAX one-day family to Europe and Korea in Q3, further strengthening our momentum. And finally, to this…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-10-14:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-10-14:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP